Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $26,988 - $28,985
218 Added 13.52%
1,830 $226,000
Q1 2024

May 30, 2024

SELL
$113.24 - $131.95 $876,251 - $1.02 Million
-7,738 Reduced 82.76%
1,612 $212,000
Q1 2024

May 08, 2024

BUY
$113.24 - $131.95 $1.06 Million - $1.23 Million
9,350 New
9,350 $1.23 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $4,838 - $5,373
47 Added 2.07%
2,313 $238,000
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $19,006 - $20,716
175 Added 8.37%
2,266 $261,000
Q1 2023

May 11, 2023

BUY
$102.94 - $114.86 $28,205 - $31,471
274 Added 15.08%
2,091 $222,000
Q4 2022

Feb 10, 2023

BUY
$87.44 - $112.11 $158,878 - $203,703
1,817 New
1,817 $201,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Peninsula Wealth, LLC Portfolio

Follow Peninsula Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peninsula Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peninsula Wealth, LLC with notifications on news.